Skip to main content
menu toggle button
About us
Who we are
Why ICS?
Our history
Our leaders
Solutions
All solutions
3PL logistics
What is 3PL?
Our 3PL services
3PL warehousing and distribution
Comparator sourcing
Order-to-cash services
Complete order-to-cash services
Contract management and chargeback processing
Customer services
Client financial services
Pharmaceutical warehousing
Storage and distribution
Enhanced serialization services
Unparalleled distribution expertise
Value beyond distribution
Cell and gene therapy
Cell and gene therapy logistics
Cryogenic transportation
Title Model solutions
Expertise
Quality management
Expert account management
Performance analytics
Our approach to analytics
ICS Analytics
Signature commercialization strategies
The Cencora network
Insights
Careers
Contact
Contact
search toggle button
Contact
Insights
Filter By
All Topics
Analytics
Cash flow management
Cell and gene therapy
Commercial supply chain
Commercialization
Data
Distribution
DSCSA
Financial management
Inventory management
Orphan drugs
Packaging
Quality
Regulatory
Secure supply chain
Technology
Third-party logistics
Sort By
Date (Newest to Oldest)
Date (Oldest to Newest)
Title (A-Z)
Title (Z-A)
Filter
AmerisourceBergen
Financial Management for Cell and Gene Therapies
Albert Cooksey
July 2018
Manufacturers
ICS: Transitioning 3PL Partners
ICS Connect
August 2017
Manufacturers
Three Ways Title Model Powers Pharma Innovation
ICS Connect
May 2017
Manufacturers
ICS: Making a case for Title Model
ICS Connect
January 2017
Manufacturers
Three Critical Components of the Specialty 3PL Experience
ICS Connect
January 2015
